Skip to main content

Table 3 Past 12-month and lifetime history of anogenital warts based on self reports

From: Systematic review of the incidence and prevalence of genital warts

Study

Country / year

Population, setting and age groups

Self-reported history of AGWs, % (95% CI)

   

Within the past 12 months

Lifetime

Matos et al., 2003 [58]

Argentina / 1998

Random sub-sample of females from 1,786 households stratified by socio-economic status; age: ≥ 15 years; N = 1,028

NA

1.8

Syrjanen et al., 2005 [59]

Argentina and Brazil / 2002–2003

Women attending four clinics as part of the Latin American Screening Study multi-center screening trial; age: 14–67 years; N = 12,107 (Argentina, [Buenos Aires]: N = 3,437; Brazil [Campinas]: N = 2,627; [Porto Alegre]: N = 3,043; [Sao Paolo]: N = 3,000)

NA

Vulvar / anal warts:

Buenos Aires: 0.4 / 0

Campinas: 2.3 / 0.3

Porto Alegre: 3.4 / 0.5

Sao Paolo: 1.1 / 0.1

Brotherton et al., 2009 [55]

Australia / 2001-02

Representative sample of the general population; age: 16–59 years; N = 9,729 males and 9,578 females

Males: 0.5*

Males: 4.0*

Females: 0.3*

Females: 4.4*

Parish et al., 2007 [61]

China

Representative sample of the general population; age: 20–64 years; N = 2,999

Males: 1.2 (0.7–2.0)

NA

Females: 2.0 (1.2–3.2)

Blomberg et al., 2010 [60]

Denmark

Random sub-samples of males and females from the general population; age: 18–45 years; N = 23,080 males

NA

Males: 7.9*

Kjaer et al., 2007 [54]

Denmark, Iceland, Norway and Sweden / 2004-05

National probability sample of general female population; age:18–45 years; N = 22,199 Denmark; 15,051 Iceland; 16,604 Norway; 15,713 Sweden

Denmark: 1.3 (1.2–1.5)*

Denmark: 10.1 (9.7–10.5)*

Iceland: 1.9 (1.7–2.1)*

Iceland: 12.0 (11.5–12.6)*

Norway: 1.1 (1.0–1.3)*

Norway: 9.5 (9.0–9.9)*

Sweden: 1.0 (0.9–1.2)*

Sweden: 11.3 (10.8–11.8)*

Fenton et al., 2001 [56]

England, Scotland and Wales / 1999-2001

National probability sample of sexually active population; age: 16–44 years; N = 5,376 males and 5,323 females

NA

Males: 3.6 (3.1–4.2)*

Females: 4.1 (3.6–4.7)*

Klavs and Grgic-Vitek, 2008 [53]

Slovenia / 1999-2001

National probability sample of sexually active population; age: 18–49 years; N = 752 males and 842 females

NA

Males: 0.27 (0–1.3)*

Females: 0.36 (0.1–1.1)*

Dinh et al., 2008 [57]

USA / 1999-2004

National probability sample of sexually active general US population; age: 18–59 years; N = 4,673 females and 4,176 males

NA

Males: 4.0 (3.2–5.0)*

    

Females: 7.2 (6.2–8.4)*

  1. * In these surveys, participants were specifically asked about clinically diagnosed warts.
  2. CI confidence interval, N: number of individuals examined or followed, NA not available.